Clinical Trial Imaging Market Size, Share, Trends, 2032

Clinical Trial Imaging Market Insights

Zion Market Research has published a report on the global Clinical Trial Imaging Market, estimating its value at USD 1287.5 Million in 2023, with projections indicating that it will reach USD 2628.37 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 7.4% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Clinical Trial Imaging Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Clinical Trial Imaging Market Overview

Imaging has traditionally played 3 roles that relate to clinical trials: detection, characterization, and monitoring/assessment. Over the last two decades, the use of imaging in clinical trials has risen exponentially. In many trials, imaging data is increasingly being used to support the primary endpoint. An increase in the number of contract research organizations, in the geriatric population with chronic diseases, and a rise in R&D expenditure are some of the factors that would drive growth of the clinical trial imaging market.

Furthermore, the emergence of pharmaceutical and biotechnology sectors, as well as of small and portable equipments market is likely to give opportunities for the clinical trial imaging market to grow. The improvements and advancements in medical imaging technology and their increasing use throughout the world are fuelling the demand for imaging technologies in clinical trials.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the unprecedented demand for hospital services severely hampered the ability to respond to non-acute health requirements. Non-COVID-19-related research activity has had to be curtailed in order to relieve the load on health-care systems, especially imaging and laboratory services. To lower the danger of infection, measures to reduce hospital visits have been implemented.

Imaging, on the other hand, necessitates hospital visits and intimate contact with workers and equipment, both of which might spread disease. Unless cleaned, equipment used to image COVID-19 patients may retain virus on its surface for days. Imaging processing is significantly slowed and throughput is reduced due to the necessity for social distancing and disinfection equipment.

Clinical Trial Imaging Market: Growth Factors

Pharmaceutical companies have grown in popularity across the world as science and technology have advanced. As the number of pharmaceutical and biotechnology companies grow, it has become increasingly important for manufacturers to provide the finest possible treatment or therapy to end users, as the companies face more competition.

The rise in demand for clinical trial imaging is primarily due to the growing geriatric population and the rising prevalence of chronic diseases. Another factor driving the growth of the clinical trial imaging market is increasing research and development capabilities for drug discovery against a variety of ailments.

Services Segment Analysis Preview

This is attributable to the fact that imaging-based clinical trials often need data management and workflow integration involving several stakeholders. Operational expertise and trial workflow development, project tracking, converting scans into digital images, regulatory control & quality assurance, real-time trial status report, setup and management of MRI centers, data management, and reporting and issue resolution are some of the services offered. Few governments across the globe have authorized the use of cloud-based servers that protect all medical imaging information, including annotated and basic pictures, protects reports from natural disasters, and allows for faster and easier retrieval.

End Use Industry Segment Analysis Preview

This is attributable to the necessity to find innovative treatments and therapies to cure chronic diseases. As the number of biotechnology and pharmaceutical businesses grows, manufacturers must provide the greatest available medicine/drug to end-users to stay competitive. As biotechnology and pharmaceutical firms make more innovative drug discoveries, the need for clinical trial imaging will rise, further boosting the market.

Clinical Trial Imaging Market: Report Scope

Clinical Trial Imaging Market: Regional Analysis Preview

This is attributable to the rising prevalence of chronic diseases and the growing geriatric population, the regional market is expected to rise. Aside from that, advancements in healthcare infrastructure have made it possible to diagnose and treat chronic diseases more efficiently. The US Food and Drug Administration (FDA) and other regulatory agencies have also played a key role in achieving trial registration objectives to date. Considering all of these factors, the regional market is expected to maintain its market position over the forecast period.

Request Free Sample

This can be attributed to the region's rapid population expansion and increased research and development activities. In addition, traditional and advanced devices and therapies are in great demand across the Asia Pacific region.

Clinical Trial Imaging Market Players & Competitive Landscape

Some of key players in clinical trial imaging market are

• Bioclinica Inc
• Ixico PLC
• Icon PLC
• Intrinsic Imaging LLC
• Radiant Sage LLC
• Parexel International Corporation
• Biomedical Systems Worldcare Clinical
• Medpace
• Navitas Life Sciences
• Prism Clinical Imaging
• Resonance Health
• VirtualScopic Inc
• BioTelemetric

The global clinical trial imaging market is segmented as follows:

By Services

• Project and Data Management
• Clinical Trial Design and Consultation
• Reading and Analytical
• Operational Imaging
• Others

By Modality

• CT
• MRI
• PET
• Ultrasound
• X-Ray
• Others

By End Use

• Biotechnology and Pharmaceutical Companies
• Medical Devices Manufacturers
• Contract Research Organizations (CROs)
• Academic and Government Research Institutes
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa